Phase III management of papulopustular rosacea with 2% green tea extract (-)EGCg in a hydrophilic cream. A placebo-controlled, double-blind study

doi:10.1016/j.jaad.2006.10.119

Phase III management of papulopustular rosacea with 2% green tea extract (-)EGCg in a hydrophilic cream. A placebo-controlled, double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2006.10.119 ◽

2007 ◽

Vol 56 (2) ◽

pp. AB15

Keyword(s):

Green Tea ◽

Green Tea Extract ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Tea Extract

Download Full-text

Management of seborrheic dermatitis with 2% analogue of green tea extract (-EGCg) in a hydrophilic cream. A placebo-controlled, double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2006.10.376 ◽

2007 ◽

Vol 56 (2) ◽

pp. AB78

Keyword(s):

Green Tea ◽

Seborrheic Dermatitis ◽

Green Tea Extract ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Tea Extract

Download Full-text

Phase II, clinical evaluation of 2% polyphenone (green tea extract) in a hydrophilic gel to assess improvement in damaged and premature aged facial skin. a placebo-controlled, double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.103 ◽

2004 ◽

Vol 50 (3) ◽

pp. P25 ◽

Cited By ~ 2

Author(s):

Tanweer A Syed ◽

Wendy H. Wong ◽

Seyed Ali Ahmad ◽

Raza Aly

Keyword(s):

Green Tea ◽

Phase Ii ◽

Clinical Evaluation ◽

Green Tea Extract ◽

Blind Study ◽

Double Blind Study ◽

Facial Skin ◽

Double Blind ◽

Tea Extract ◽

Hydrophilic Gel

Download Full-text

Management of melasma with 2% analogue of green tea extract in a hydrophilic cream: A placebo-controlled, double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2008.11.702 ◽

2009 ◽

Vol 60 (3) ◽

pp. AB160

Keyword(s):

Green Tea ◽

Green Tea Extract ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Tea Extract

Download Full-text

Management of papulopustular rosacea with 2% polyphenone (green tea extract) in a hydrophilic cream: A placebo-controlled double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2004.10.035 ◽

2005 ◽

Vol 52 (3) ◽

pp. P5

Keyword(s):

Green Tea ◽

Green Tea Extract ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Tea Extract

Download Full-text

Phase II management of seborrheic dermatitis with 2% analogue of green tea extract in a hydrophilic cream: A placebo-controlled, double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2008.11.747 ◽

2009 ◽

Vol 60 (3) ◽

pp. AB171

Keyword(s):

Green Tea ◽

Phase Ii ◽

Seborrheic Dermatitis ◽

Green Tea Extract ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Tea Extract

Download Full-text

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Download Full-text

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkq254 ◽

2010 ◽

Vol 65 (Supplement 4) ◽

pp. iv41-iv51 ◽

Cited By ~ 64

Author(s):

G. R. Corey ◽

M. H. Wilcox ◽

G. H. Talbot ◽

D. Thye ◽

D. Friedland ◽

...

Keyword(s):

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Ceftaroline Fosamil ◽

Skin Structure ◽

Complicated Skin

Download Full-text

Green tea extract outperforms metformin in lipid profile and glycaemic control in overweight women: A double-blind, placebo-controlled, randomized trial

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2017.08.008 ◽

2017 ◽

Vol 22 ◽

pp. 1-6 ◽

Cited By ~ 5

Author(s):

Monallisa Alves Ferreira ◽

Anna Paula Oliveira Gomes ◽

Ana Paula Guimarães de Moraes ◽

Maria Luiza Ferreira Stringhini ◽

João Felipe Mota ◽

...

Keyword(s):

Glycaemic Control ◽

Randomized Trial ◽

Lipid Profile ◽

Green Tea ◽

Green Tea Extract ◽

Double Blind ◽

Double Blind Placebo ◽

Overweight Women ◽

Tea Extract

Download Full-text

Survival advantage of exemestane (EXE, Aromasin®) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind study

European Journal of Cancer ◽

10.1016/s0959-8049(99)80705-9 ◽

1999 ◽

Vol 35 ◽

pp. S84 ◽

Cited By ~ 2

Author(s):

E. Bajetta ◽

L.Y. Dirix ◽

L.E. Fein ◽

S.E. Jones ◽

J. Cervek ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Survival Advantage ◽

Advanced Breast ◽

Blind Study ◽

Megestrol Acetate ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind

Download Full-text

Patient-reported outcomes (PROs) from TITAN: A phase III, randomized, double-blind study of apalutamide (APA) versus placebo (PBO) added to androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC)

Annals of Oncology ◽

10.1093/annonc/mdz248.008 ◽

2019 ◽

Vol 30 ◽

pp. v330-v331

Author(s):

N. Agarwal ◽

K. McQuarrie ◽

A. Bjartell ◽

S. Chowdhury ◽

A J P D S Gomes ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Patient Reported Outcomes ◽

Androgen Deprivation ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Patient Reported

Download Full-text